• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关注原发性骨髓纤维化中的骨硬化进展。

Focus on Osteosclerotic Progression in Primary Myelofibrosis.

作者信息

Spampinato Mariarita, Giallongo Cesarina, Romano Alessandra, Longhitano Lucia, La Spina Enrico, Avola Roberto, Scandura Grazia, Dulcamare Ilaria, Bramanti Vincenzo, Di Rosa Michelino, Vicario Nunzio, Parenti Rosalba, Li Volti Giovanni, Tibullo Daniele, Palumbo Giuseppe A

机构信息

Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.

Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, 95123 Catania, Italy.

出版信息

Biomolecules. 2021 Jan 19;11(1):122. doi: 10.3390/biom11010122.

DOI:10.3390/biom11010122
PMID:33477816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7832894/
Abstract

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by hematopoietic stem-cell-derived clonal proliferation, leading to bone marrow (BM) fibrosis. Hematopoiesis alterations are closely associated with modifications of the BM microenvironment, characterized by defective interactions between vascular and endosteal niches. As such, neoangiogenesis, megakaryocytes hyperplasia and extensive bone marrow fibrosis, followed by osteosclerosis and bone damage, are the most relevant consequences of PMF. Moreover, bone tissue deposition, together with progressive fibrosis, represents crucial mechanisms of disabilities in patients. Although the underlying mechanisms of bone damage observed in PMF are still unclear, the involvement of cytokines, growth factors and bone marrow microenvironment resident cells have been linked to disease progression. Herein, we focused on the role of megakaryocytes and their alterations, associated with cytokines and chemokines release, in modulating functions of most of the bone marrow cell populations and in creating a complex network where impaired signaling strongly contributes to progression and disabilities.

摘要

原发性骨髓纤维化(PMF)是一种骨髓增殖性肿瘤,其特征为造血干细胞来源的克隆性增殖,导致骨髓(BM)纤维化。造血改变与BM微环境的改变密切相关,其特征是血管龛和骨内膜龛之间的相互作用存在缺陷。因此,新生血管形成、巨核细胞增生和广泛的骨髓纤维化,随后出现骨硬化和骨损伤,是PMF最相关的后果。此外,骨组织沉积以及进行性纤维化是患者致残的关键机制。虽然PMF中观察到的骨损伤潜在机制仍不清楚,但细胞因子、生长因子和骨髓微环境驻留细胞的参与与疾病进展有关。在此,我们重点关注巨核细胞的作用及其改变,这些改变与细胞因子和趋化因子的释放相关,在调节大多数骨髓细胞群体的功能以及创建一个复杂网络方面发挥作用,在这个网络中受损的信号传导强烈促进疾病进展和致残。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7832894/40a47706fa96/biomolecules-11-00122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7832894/c3714d48bf84/biomolecules-11-00122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7832894/40a47706fa96/biomolecules-11-00122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7832894/c3714d48bf84/biomolecules-11-00122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/084d/7832894/40a47706fa96/biomolecules-11-00122-g002.jpg

相似文献

1
Focus on Osteosclerotic Progression in Primary Myelofibrosis.关注原发性骨髓纤维化中的骨硬化进展。
Biomolecules. 2021 Jan 19;11(1):122. doi: 10.3390/biom11010122.
2
Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.原发性骨髓纤维化骨髓来源的 CD14+/CD34- 单核细胞在免疫缺陷小鼠中诱导骨髓纤维化样表型,并产生巨核细胞。
PLoS One. 2019 Sep 30;14(9):e0222912. doi: 10.1371/journal.pone.0222912. eCollection 2019.
3
Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.内皮素-1在骨髓纤维化和骨硬化综合征中的作用
J Clin Endocrinol Metab. 2015 Nov;100(11):3971-4. doi: 10.1210/jc.2015-2729. Epub 2015 Sep 10.
4
Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.非经典TGF-β1信号通路的激活表明原发性骨髓纤维化中骨髓纤维化的自身免疫机制。
Blood Cells Mol Dis. 2015 Mar;54(3):234-41. doi: 10.1016/j.bcmd.2014.12.005. Epub 2015 Jan 15.
5
Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis.原发性骨髓纤维化患者骨髓间充质基质细胞的转录组分析
Genom Data. 2015 Apr 29;5:1-2. doi: 10.1016/j.gdata.2015.04.017. eCollection 2015 Sep.
6
Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.骨形态发生蛋白在原发性骨髓纤维化的骨髓中过度表达,且明显由促纤维化细胞因子诱导产生。
Am J Pathol. 2008 Apr;172(4):951-60. doi: 10.2353/ajpath.2008.071030. Epub 2008 Mar 18.
7
Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.在 Jak2V617F 诱导的原发性骨髓纤维化小鼠中,肿瘤纤维母细胞在骨髓纤维化中发挥重要作用。
Leukemia. 2021 Feb;35(2):454-467. doi: 10.1038/s41375-020-0880-3. Epub 2020 May 29.
8
Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.骨髓增生性疾病中的间充质干细胞 - 聚焦原发性骨髓纤维化。
Leuk Lymphoma. 2019 Apr;60(4):876-885. doi: 10.1080/10428194.2018.1516881. Epub 2018 Oct 2.
9
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.造血细胞中 CXCL4 表达增加将炎症与 MPN 骨髓纤维化的进展联系起来。
Blood. 2020 Oct 29;136(18):2051-2064. doi: 10.1182/blood.2019004095.
10
Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice.原发性骨髓纤维化患者循环中的 CD34+ 细胞有助于免疫缺陷小鼠中以髓系为主的造血和骨髓纤维化。
Int J Hematol. 2022 Feb;115(2):198-207. doi: 10.1007/s12185-021-03239-y. Epub 2021 Nov 13.

引用本文的文献

1
Fat Fraction MRI for Longitudinal Assessment of Bone Marrow Heterogeneity in a Mouse Model of Myelofibrosis.脂肪分数磁共振成像用于纵向评估骨髓纤维化小鼠模型中的骨髓异质性
Tomography. 2025 Jul 28;11(8):82. doi: 10.3390/tomography11080082.
2
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis.乳酸积累促进骨髓纤维化中骨髓微环境的免疫抑制和纤维化转变。
J Transl Med. 2025 Jan 14;23(1):69. doi: 10.1186/s12967-025-06083-4.
3
Endothelial LATS2 is a suppressor of bone marrow fibrosis.

本文引用的文献

1
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.芦可替尼治疗骨髓纤维化患者的第二原发性恶性肿瘤。
Br J Haematol. 2021 Apr;193(2):356-368. doi: 10.1111/bjh.17192. Epub 2020 Nov 21.
2
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.造血细胞中 CXCL4 表达增加将炎症与 MPN 骨髓纤维化的进展联系起来。
Blood. 2020 Oct 29;136(18):2051-2064. doi: 10.1182/blood.2019004095.
3
The Role of Inflammation and Inflammasome in Myeloproliferative Disease.
内皮细胞的大肿瘤抑制激酶2是骨髓纤维化的一种抑制因子。
Nat Cardiovasc Res. 2024;3(8):951-969. doi: 10.1038/s44161-024-00508-x. Epub 2024 Jul 29.
4
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients.靶向代谢组学揭示原发性骨髓纤维化患者血清中抗氧化剂显著消耗、氧化/亚硝化应激增加以及嘌呤和嘧啶浓度改变。
Antioxidants (Basel). 2024 Apr 19;13(4):490. doi: 10.3390/antiox13040490.
5
Haplodeficiency of the 9p21 tumor suppressor locus causes myeloid disorders driven by the bone marrow microenvironment.9p21 肿瘤抑制基因座杂合缺失导致骨髓微环境驱动的髓系疾病。
Blood. 2023 Aug 3;142(5):460-476. doi: 10.1182/blood.2022018512.
6
Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis.骨髓增生性肿瘤患者骨髓中髓源性抑制细胞频率增加:在骨髓纤维化中的潜在影响。
Adv Exp Med Biol. 2023;1408:273-290. doi: 10.1007/978-3-031-26163-3_15.
7
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases.肿瘤微环境中间充质基质细胞对BCR-ABL阴性骨髓增殖性疾病的重塑作用
Front Oncol. 2023 Feb 23;13:1141610. doi: 10.3389/fonc.2023.1141610. eCollection 2023.
8
L. Leaves as a Potential Food Source of Phenolic Compounds with Biological Activity.L. 树叶作为具有生物活性的酚类化合物的潜在食物来源。
Antioxidants (Basel). 2022 Jun 30;11(7):1313. doi: 10.3390/antiox11071313.
9
Osteolytic lesion in polycythemia vera: First report and review of literature.真性红细胞增多症中的溶骨性病变:首例报告及文献综述
EJHaem. 2022 Mar 27;3(2):526-532. doi: 10.1002/jha2.420. eCollection 2022 May.
10
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis.IGFBP-6/sonic hedgehog/TLR4 信号轴驱动原发性骨髓纤维化中的骨髓纤维化转化。
Aging (Albany NY). 2021 Dec 14;13(23):25055-25071. doi: 10.18632/aging.203779.
炎症及炎性小体在骨髓增殖性疾病中的作用
J Clin Med. 2020 Jul 22;9(8):2334. doi: 10.3390/jcm9082334.
4
Immunoproteasome Genes Are Modulated in CD34 JAK2 Mutated Cells from Primary Myelofibrosis Patients.免疫蛋白酶体基因在原发性骨髓纤维化患者的 CD34 JAK2 突变细胞中受到调节。
Int J Mol Sci. 2020 Apr 22;21(8):2926. doi: 10.3390/ijms21082926.
5
Management of myelofibrosis after ruxolitinib failure.芦可替尼治疗失败后的骨髓纤维化的管理。
Ann Hematol. 2020 Jun;99(6):1177-1191. doi: 10.1007/s00277-020-04002-9. Epub 2020 Mar 20.
6
Myelofibrosis biology and contemporary management.骨髓纤维化生物学与当代管理。
Br J Haematol. 2020 Oct;191(2):152-170. doi: 10.1111/bjh.16576. Epub 2020 Mar 20.
7
IL-33/IL-31 Axis in Osteoporosis.IL-33/IL-31 轴在骨质疏松症中的作用。
Int J Mol Sci. 2020 Feb 13;21(4):1239. doi: 10.3390/ijms21041239.
8
Ixazomib Improves Bone Remodeling and Counteracts sonic Hedgehog signaling Inhibition Mediated by Myeloma Cells.伊沙佐米改善骨重塑并抵消骨髓瘤细胞介导的音猬因子信号通路抑制作用。
Cancers (Basel). 2020 Jan 30;12(2):323. doi: 10.3390/cancers12020323.
9
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib.芦可替尼抗炎和免疫抑制活性的潜在机制。
Front Oncol. 2019 Nov 7;9:1186. doi: 10.3389/fonc.2019.01186. eCollection 2019.
10
mTOR Links Tumor Immunity and Bone Metabolism: What are the Clinical Implications?mTOR 连接肿瘤免疫和骨代谢:有哪些临床意义?
Int J Mol Sci. 2019 Nov 21;20(23):5841. doi: 10.3390/ijms20235841.